Salvage ipilimumab associated with a significant response in sarcomatoid renal cell carcinoma

BACKGROUND: Metastatic sarcomatoid renal cell carcinoma (sRCC) is an aggressive variant of RCC with generally poor prognosis. Treatment with vascular endothelial growth factor inhibitors or chemotherapy generates only short-lived responses. Recent research has suggested a role for combination checkp...

Descripción completa

Detalles Bibliográficos
Autores principales: George, Gemlyn, Schmidt, Laura, Tolat, Parag, Riese, Mathew, Kilari, Deepak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057424/
https://www.ncbi.nlm.nih.gov/pubmed/32114501
http://dx.doi.org/10.1136/jitc-2020-000584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057424/
https://www.ncbi.nlm.nih.gov/pubmed/32114501
http://dx.doi.org/10.1136/jitc-2020-000584

Ejemplares similares